Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anetta Nowosielska is active.

Publication


Featured researches published by Anetta Nowosielska.


Cell | 2011

Adaptation to P Element Transposon Invasion in Drosophila melanogaster

Jaspreet S. Khurana; Jie Wang; Jia Xu; Birgit S. Koppetsch; Travis Thomson; Anetta Nowosielska; Chengjian Li; Phillip D. Zamore; Zhiping Weng; William E. Theurkauf

Transposons evolve rapidly and can mobilize and trigger genetic instability. Piwi-interacting RNAs (piRNAs) silence these genome pathogens, but it is unclear how the piRNA pathway adapts to invasion of new transposons. In Drosophila, piRNAs are encoded by heterochromatic clusters and maternally deposited in the embryo. Paternally inherited P element transposons thus escape silencing and trigger a hybrid sterility syndrome termed P-M hybrid dysgenesis. We show that P-M hybrid dysgenesis activates both P elements and resident transposons and disrupts the piRNA biogenesis machinery. As dysgenic hybrids age, however, fertility is restored, P elements are silenced, and P element piRNAs are produced de novo. In addition, the piRNA biogenesis machinery assembles, and resident elements are silenced. Significantly, resident transposons insert into piRNA clusters, and these new insertions are transmitted to progeny, produce novel piRNAs, and are associated with reduced transposition. P element invasion thus triggers heritable changes in genome structure that appear to enhance transposon silencing.


Nature | 2015

HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation

Annachiara Rosa; Ajit Chande; Serena Ziglio; Veronica De Sanctis; Roberto Bertorelli; Shih Lin Goh; Sean M. McCauley; Anetta Nowosielska; Jeremy Luban; Federico Santoni; Massimo Pizzato

HIV-1 Nef, a protein important for the development of AIDS, has well-characterized effects on host membrane trafficking and receptor downregulation. By an unidentified mechanism, Nef increases the intrinsic infectivity of HIV-1 virions in a host-cell-dependent manner. Here we identify the host transmembrane protein SERINC5, and to a lesser extent SERINC3, as a potent inhibitor of HIV-1 particle infectivity that is counteracted by Nef. SERINC5 localizes to the plasma membrane, where it is efficiently incorporated into budding HIV-1 virions and impairs subsequent virion penetration of susceptible target cells. Nef redirects SERINC5 to a Rab7-positive endosomal compartment and thereby excludes it from HIV-1 particles. The ability to counteract SERINC5 was conserved in Nef encoded by diverse primate immunodeficiency viruses, as well as in the structurally unrelated glycosylated Gag from murine leukaemia virus. These examples of functional conservation and convergent evolution emphasize the fundamental importance of SERINC5 as a potent anti-retroviral factor.


Diabetes | 2015

Novel Observations From Next-Generation RNA Sequencing of Highly Purified Human Adult and Fetal Islet Cell Subsets.

David M. Blodgett; Anetta Nowosielska; Shaked Afik; Susanne Pechhold; Anthony J. Cura; Norman J. Kennedy; Soyoung Kim; Alper Kucukural; Roger J. Davis; Sally C. Kent; Dale L. Greiner; Manuel Garber; David M. Harlan; Philip diIorio

Understanding distinct gene expression patterns of normal adult and developing fetal human pancreatic α- and β-cells is crucial for developing stem cell therapies, islet regeneration strategies, and therapies designed to increase β-cell function in patients with diabetes (type 1 or 2). Toward that end, we have developed methods to highly purify α-, β-, and δ-cells from human fetal and adult pancreata by intracellular staining for the cell-specific hormone content, sorting the subpopulations by flow cytometry, and, using next-generation RNA sequencing, we report the detailed transcriptomes of fetal and adult α- and β-cells. We observed that human islet composition was not influenced by age, sex, or BMI, and transcripts for inflammatory gene products were noted in fetal β-cells. In addition, within highly purified adult glucagon-expressing α-cells, we observed surprisingly high insulin mRNA expression, but not insulin protein expression. This transcriptome analysis from highly purified islet α- and β-cell subsets from fetal and adult pancreata offers clear implications for strategies that seek to increase insulin expression in type 1 and type 2 diabetes.


Nucleic Acids Research | 2006

Homologous recombination prevents methylation-induced toxicity in Escherichia coli

Anetta Nowosielska; Stephen A. Smith; Bevin P. Engelward; Martin G. Marinus

Methylating agents such as N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) and methyl methane sulfonate (MMS) produce a wide variety of N- and O-methylated bases in DNA, some of which can block replication fork progression. Homologous recombination is a mechanism by which chromosome replication can proceed despite the presence of lesions. The two major recombination pathways, RecBCD and RecFOR, which repair double-strand breaks (DSBs) and single-strand gaps respectively, are needed to protect against toxicity with the RecBCD system being more important. We find that recombination-deficient cell lines, such as recBCD recF, and ruvC recG, are as sensitive to the cytotoxic effects of MMS and MNNG as the most base excision repair (BER)-deficient (alkA tag) isogenic mutant strain. Recombination and BER-deficient double mutants (alkA tag recBCD) were more sensitive to MNNG and MMS than the single mutants suggesting that homologous recombination and BER play essential independent roles. Cells deleted for the polA (DNA polymerase I) or priA (primosome) genes are as sensitive to MMS and MNNG as alkA tag bacteria. Our results suggest that the mechanism of cytotoxicity by alkylating agents includes the necessity for homologous recombination to repair DSBs and single-strand gaps produced by DNA replication at blocking lesions or single-strand nicks resulting from AP-endonuclease action.


Nucleic Acids Research | 2005

Separation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutant

Melissa A. Calmann; Anetta Nowosielska; Martin G. Marinus

DNA mismatch repair in Escherichia coli has been shown to be involved in two distinct processes: mutation avoidance, which removes potential mutations arising as replication errors, and antirecombination which prevents recombination between related, but not identical (homeologous), DNA sequences. We show that cells with the mutSΔ800 mutation (which removes the C-terminal 53 amino acids of MutS) on a multicopy plasmid are proficient for mutation avoidance. In interspecies genetic crosses, however, recipients with the mutSΔ800 mutation show increased recombination by up to 280-fold relative to mutS+. The MutSΔ800 protein binds to O6-methylguanine mismatches but not to intrastrand platinated GG cross-links, explaining why dam bacteria with the mutSΔ800 mutation are resistant to cisplatin, but not MNNG, toxicity. The results indicate that the C-terminal end of MutS is necessary for antirecombination and cisplatin sensitization, but less significant for mutation avoidance. The inability of MutSΔ800 to form tetramers may indicate that these are the active form of MutS.


Journal of Bacteriology | 2005

The MutS C Terminus Is Essential for Mismatch Repair Activity In Vivo

Melissa A. Calmann; Anetta Nowosielska; Martin G. Marinus

An Escherichia coli K-12 strain was constructed with a chromosomal deletion (mutSdelta800) in the mutS gene that produced the removal of the C-terminal 53 amino acids which are not present in the MutS crystal structure. This strain has a MutS null phenotype for mutation avoidance, anti-recombination, and sensitivity to cytotoxic agents in a dam mutant background.


The FASEB Journal | 2016

Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β

Agata Jurczyk; Anetta Nowosielska; Natalia Przewozniak; Ken-Edwin Aryee; Philip diIorio; David M. Blodgett; Chaoxing Yang; Martha Campbell-Thompson; Mark A. Atkinson; Leonard D. Shultz; Ann R. Rittenhouse; David M. Harlan; Dale L. Greiner; Rita Bortell

Individuals with schizophrenia and their first‐degree relatives have higher rates of type 2 diabetes (T2D) than the general population (18–30 vs. 1.2–6.3%), independent of body mass index and antipsychotic medication, suggesting shared genetic components may contribute to both diseases. The cause of this association remains unknown. Mutations in disrupted in schizophrenia 1 (DISC1) increase the risk of developing psychiatric disorders [logarithm (base 10) of odds = 7.1]. Here, we identified DISC1 as a major player controlling pancreatic β‐cell proliferation and insulin secretion via regulation of glycogen synthase kinase‐3β (GSK3β). DISC1 expression was enriched in developing mouse and human pancreas and adult β‐ and ductal cells. Loss of DISC1 function, through siRNA‐mediated depletion or expression of a dominant‐negative truncation that models the chromosomal translocation of human DISC1 in schizophrenia, resulted in decreased β‐cell proliferation (3 vs. 1%; P< 0.01), increased apoptosis (0.1 vs. 0.6%; P< 0.01), and glucose intolerance in transgenic mice. Insulin secretion was reduced (0.5 vs. 0.1 ng/ml; P < 0.05), and critical β‐cell transcription factors Pdx1 and Nkx6.1 were significantly decreased. Impaired DISC1 allowed inappropriate activation of GSK3β in β cells, and antagonizing GSK3β (SB216763; IC50 = 34.3 nM) rescued the β‐cell defects. These results uncover an unexpected role for DISC1 in normal β‐cell physiology and suggest that DISC1 dysregulation contributes to T2D independently of its importance for cognition.—Jurczyk, A., Nowosielska, A., Przewozniak, N., Aryee, K.‐E., DiIorio, P., Blodgett, D., Yang, C., Campbell‐Thompson, M., Atkinson, M., Shultz, L., Rittenhouse, A., Harlan, D., Greiner, D., Bortell, R. Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β‐cell function via glycogen synthase kinase‐3β. FASEB J. 30, 983–993 (2016). www.fasebj.org


bioRxiv | 2018

Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines

Sean M. McCauley; Kyusik Kim; Anetta Nowosielska; Ann Dauphin; Leonid Yurkovetskiy; William E. Diehl; Jeremy Luban

HIV-1-infected people who take drugs that suppress viremia to undetectable levels are protected from developing AIDS. Nonetheless, these individuals have chronic inflammation associated with heightened risk of cardiovascular pathology. HIV-1 establishes proviruses in long-lived CD4+ memory T cells, and perhaps other cell types, that preclude elimination of the virus even after years of continuous antiviral therapy. Though the majority of proviruses that persist during antiviral therapy are defective for production of infectious virions, many are expressed, raising the possibility that the HIV-1provirus or its transcripts contribute to ongoing inflammation. Here we found that the HIV-1 provirus activated innate immune signaling in isolated dendritic cells, macrophages, and CD4+ T cells. Immune activation required transcription from the HIV-1 provirus and expression of CRM1-dependent, Rev-dependent, RRE-containing, unspliced HIV-1 RNA. If rev was provided in trans, all HIV-1 coding sequences were dispensable for activation except those cis-acting sequences required for replication or splicing. These results indicate that the complex, post-transcriptional regulation intrinsic to HIV-1 RNA is detected by the innate immune system as a danger signal, and that drugs which disrupt HIV-1 transcription or HIV-1 RNA metabolism would add qualitative benefit to current antiviral drug regimens.


Cell systems | 2018

Comparative Analysis of Immune Cells Reveals a Conserved Regulatory Lexicon

Elisa Donnard; Pranitha Vangala; Shaked Afik; Sean M. McCauley; Anetta Nowosielska; Alper Kucukural; Barbara Tabak; Xiaopeng Zhu; William E. Diehl; Patrick McDonel; Nir Yosef; Jeremy Luban; Manuel Garber

Most well-characterized enhancers are deeply conserved. In contrast, genome-wide comparative studies of steady-state systems showed that only a small fraction of active enhancers are conserved. To better understand conservation of enhancer activity, we used a comparative genomics approach that integrates temporal expression and epigenetic profiles in an innate immune system. We found that gene expression programs diverge among mildly induced genes, while being highly conserved for strongly induced genes. The fraction of conserved enhancers varies greatly across gene expression programs, with induced genes and early-response genes, in particular, being regulated by a higher fraction of conserved enhancers. Clustering of conserved accessible DNA sequences within enhancers resulted in over 60 sequence motifs including motifs for known factors, as well as many with unknown function. We further show that the number of instances of these motifs is a strong predictor of the responsiveness of a gene to pathogen detection.


DNA Repair | 2005

Cisplatin induces DNA double-strand break formation in Escherichia coli dam mutants

Anetta Nowosielska; Martin G. Marinus

Collaboration


Dive into the Anetta Nowosielska's collaboration.

Top Co-Authors

Avatar

Martin G. Marinus

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Jeremy Luban

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Melissa A. Calmann

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Sean M. McCauley

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Alper Kucukural

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Dale L. Greiner

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

David M. Blodgett

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

David M. Harlan

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Manuel Garber

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Philip diIorio

University of Massachusetts Medical School

View shared research outputs
Researchain Logo
Decentralizing Knowledge